期刊文献+

VEGF-C反义寡核苷酸和姜黄素联合化疗对卵巢癌细胞SKOV3生长、粘附、侵袭能力的抑制作用 被引量:1

INHIBITION OF VEGF-C ASODN AND CURCUMIN COMBINATION CHEMOTHERAPY ON PROLIFERATION AND ADHESION AND INVASION OF OVARY CANCER SKOV3 CELLS
下载PDF
导出
摘要 目的探讨VEGF-C反义寡核苷酸(VEGF-C ASODN)和姜黄素联合化疗对人卵巢癌细胞SKOV3生长粘附侵袭能力的抑制作用。方法 MTT法检测VEGF-C ASODN和姜黄素联合化疗对卵巢癌细胞的增殖抑制效应;MTT法检测卵巢癌细胞与细胞外基质粘附能力,体外侵袭实验检测卵巢癌细胞侵袭人工基底膜的能力。结果 VEGF-C ASODN和姜黄素联合化疗对卵巢癌细胞有明显的增殖抑制作用,使卵巢癌细胞对细胞外基质粘附率明显降低,穿透重组基质膜数目明显下降。结论 VEGF-C ASODN和姜黄素联合化疗能明显抑制卵巢癌细胞体外实验中的生长粘附侵袭能力,可望为卵巢癌提供一种有效的联合化疗方法。 Objective To investigate the inhibition of VEGF - C antisense oligodeoxynucleotide (ASODN) and curcumin combination chemotherapy on the proliferation and adhesion and invasion of human ovary cancer cell line SKOV3 in vitro. Methods The ovary cancer cell proliferation in VEGF - C ASODN and curcumin combination chemotherapy was detected by MTI'. The adhesion to artifical basement membrane Matrigel was measured by MTI" assay. The invasion was evaluated by Tran swell chambers attached with polycarbonate filters and reconstituted basement membrane (Matrigel). Results VEGF - C ASODN and curcumin combination chemotherapy could significantly inhibit the growth of SKOV3 cells. The adhesive and invasive cell numbers decreased markedly. Con- clusion VEGF - C ASODN and curcumin combination chemotherapy could inhibit the proliferation and adhesion and invasion of SK- OV3 cells remarkably and could provide effective combination chemotherapy for ovarian cancer.
出处 《现代医院》 2012年第8期3-5,共3页 Modern Hospitals
关键词 卵巢肿瘤 联合化疗 VEGF-C 反义寡核苷酸 姜黄素 Ovary neoplasms, Combination chemotherapy, VEGF - C, Antisense oligodeoxynucleotide, Cm^umin
  • 相关文献

参考文献20

  • 1吴琼,陈道桢.卵巢癌相关肿瘤标志物的研究进展[J].实用医学杂志,2011,27(8):1499-1500. 被引量:6
  • 2周冬梅,生秀杰.肿瘤转移抑制基因与卵巢癌[J].实用医学杂志,2011,27(7):1306-1308. 被引量:3
  • 3MANDRIOTA S J,JUSSILA L,JELTSCH M,et al.Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis[J].EMBO J,2001,20(4):672-682.
  • 4JORGENSEN T J,HELZLSOUER K J,CLIPP S C,et al.DNA repair gene variants associated with benign breast disease in high cancer risk women[J].Cancer Epidemiol Biomarkers Prev,2009,18:346-350.
  • 5SAHARINEN P,PETROVA T V.Molecular regulation of lymphangiogenesis[J].Ann N Y Acad Sci,2004,1014(3):762-771.
  • 6SCHNEIDER M,BUCHLER P,GIESE N,et al.Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread[J].Int J Oncol,2006,28(4):883-890.
  • 7DAYANIR V,MEYER RD,LASHKARI K,et al.Identification of tyrosine residues in vascular endothehal growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation[J].J Biol Chem,2001,276(21):17686-17692.
  • 8UEDA M,HUNG Y C,TERAI Y,et al.Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas[J].Clin Cancer Res,2005,11(9):3225-3232.
  • 9MICHIYO KODAMA,YASUHIKO KITADAI,MIWAKO TANAKA,et al.Vascular Endothelial Growth Factor C Stimulates Progression of Human Gastric Cancer via Both Autocrine and Paracrine Mechanisms[J].Clin Cancer Res,2008,14:7205-7214.
  • 10MING-HSIEN CHIENL,CHIA-CHI KUL,GUNNAR JOHANSSONL,et al.Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway[J].Carcinogenesis,2009,30:2005-2013.

二级参考文献70

共引文献34

同被引文献18

  • 1吴锦银.RNAi技术综述[J].现代医院,2006,6(12):6-7. 被引量:4
  • 2吴伟东,方驰华.RNA干扰技术抑制哺乳动物细胞绿色荧光蛋白表达的研究[J].现代医院,2007,7(2):4-8. 被引量:2
  • 3FORSTER R,DAVALOS-MISSLITZ A C,ROT A.CCR7 and its ligands:balancing immunity and tolerance[J].Nat Rev Immunol,2008,8(5):362-371.
  • 4IRINO T,TAKEUCHI H,MATSUDA S,et al.CC-Chemokine receptor CCR7:a key molecule for lymph node metastasis in esophageal squamous cell carcinoma[J].BMC Cancer,2014,14:291.
  • 5PALACIOS-ARREOLA M I,NAVA-CASTRO K E,CASTRO J I,et al.The role of chemokines in breast cancer pathology and its possible use as therapeutic targets[J/OL].J Immunol Res,2014.http://dx.doi.org/10.1155/2014/849720.
  • 6LEGLER D F,UETZ-VON ALLMEN E,HAUSER M A.CCR7:roles in cancer cell dissemination,migration and metastasis formation[J].Int J Biochem Cell Biol,2014,54:78-82.
  • 7SOMOVILLA-CRESPO B,ALFONSO-PEREZ M,CUESTAMATEOS C,et al.Anti-CCR7 therapy exerts a potent antitumor activity in a xenograft model of human mantle cell lymphoma[J].J Hematol Oncol,2013,6:89.
  • 8RAMAN D,SOBOLIK-DELMAIRE T,RICHMOND A.Chemokines in health and disease[J].Exp Cell Res,2011,317(5):575-589.
  • 9SARVAIYA P J,GUO D,ULASOV I,et al.Chemokines in tumor progression and metastasis[J].Oncotarget,2013,4(12):2171-2185.
  • 10TUTUNEA-FATAN E,MAJUMDER M,XIN X,et al.The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis[J].Mol Cancer,2015,14(1):35.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部